Clinical trial Recruiting at 1 site Interventional Ages 9 to 13

Comparing rhythm perception in children who stutter and those who don't

Official title: Subcortical Network Connectivity and Temporal Processing in Children With Persistent and Recovered Stuttering

Run by University of Michigan · NCT05286151 · Data updated 2026-11-12

This study tests how children who stutter perceive and produce rhythm compared to those who don’t, using fun tasks and brain scans to learn more about stuttering.

Quick facts

Study typeInterventional
Ages9 Years to 13 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedJuly 23, 2022
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedOctober 15, 2026
Trial IDNCT05286151 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children aged 5-18 who have a current or past diagnosis of stuttering, as well as healthy children who do not stutter.

Probably not a fit

Patients with neurological or psychiatric conditions, major medical illnesses, or significant hearing loss may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the differences in rhythm perception and production between children who stutter and those who do not. Over a period of three years, participants will engage in rhythm discrimination and finger tapping tasks annually. Additionally, the study will incorporate MRI scans to investigate the relationship between rhythm performance and brain activity. The goal is to better understand the neurological underpinnings of stuttering through these assessments.

Why it matters

Potential benefit: If successful, this study could lead to improved therapeutic approaches for children who stutter by enhancing our understanding of their rhythm processing abilities.

How similar studies have gone: While the specific approach of this study is novel, previous research has indicated a connection between rhythm processing and speech disorders, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria Children who stutter:

* English as primary language
* Current or past stuttering diagnosis

Inclusion Criteria Children who do not stutter:

* English as primary language

Exclusion Criteria Children who stutter:

* Diagnosed/under treatment for any neurological or psychiatric conditions
* Head trauma with loss of consciousness
* Major medical illness
* Hearing loss- Language/motor delay (below -2 standard deviations on standardized assessments)
* Face, motor, or reflex abnormalities

Exclusion Criteria Children who do not stutter:

* Personal or family history of stuttering
* Diagnosed/under treatment for any neurological or psychiatric conditions
* Head trauma with loss of consciousness
* Major medical illness
* Hearing loss
* Language/motor delay (below -2 standard deviations on standardized assessments
* Face, motor, or reflex abnormalities

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Soo-Eun Chang, PhD — University of Michigan
  • Study coordinator: Soo-Eun Chang, PhD
  • Email: sooeunc@umich.edu
  • Phone: 734-232-0300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.